Cargando…

Harnessing human plasmacytoid dendritic cells as professional APCs

The plasmacytoid dendritic cell (pDC) constitutes a unique DC subset that links the innate and adaptive arm of the immune system. Whereas the unique capability of pDCs to produce large amounts of type I IFNs in response to pathogen recognition is generally accepted, their antigen-presenting function...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tel, Jurjen, van der Leun, Anne M., Figdor, Carl G., Torensma, Ruurd, de Vries, I. Jolanda M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2012
Materias:	Focussed Research Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401502/ https://www.ncbi.nlm.nih.gov/pubmed/22294456 http://dx.doi.org/10.1007/s00262-012-1210-z

Ejemplares similares

Opportunities for immunotherapy in microsatellite instable colorectal cancer
por: Westdorp, Harm, et al.
Publicado: (2016)

The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues
por: Tel, Jurjen, et al.
Publicado: (2011)

Preclinical exploration of combining plasmacytoid and myeloid dendritic cell vaccination with BRAF inhibition
por: Tel, Jurjen, et al.
Publicado: (2016)

Naturally circulating dendritic cells to vaccinate cancer patients
por: Bol, Kalijn F., et al.
Publicado: (2013)

Single-cell analysis reveals that stochasticity and paracrine signaling control interferon-alpha production by plasmacytoid dendritic cells
por: Wimmers, Florian, et al.
Publicado: (2018)

Tumoricidal activity of human dendritic cells
por: Tel, Jurjen, et al.
Publicado: (2014)

Harnessing the antigenic fingerprint of each individual cancer for immunotherapy of human cancer: genomics shows a new way and its challenges
por: Srivastava, Pramod K., et al.
Publicado: (2013)

Microenvironmental derived factors modulating dendritic cell function and vaccine efficacy: the effect of prostanoid receptor and nuclear receptor ligands
por: Raaijmakers, Tonke K., et al.
Publicado: (2018)

A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets
por: Sittig, Simone P., et al.
Publicado: (2016)

Human Plasmacytoid Dendritic Cells: From Molecules to Intercellular Communication Network
por: Mathan, Till S. M., et al.
Publicado: (2013)

Phenotypical Diversification of Early IFNα-Producing Human Plasmacytoid Dendritic Cells Using Droplet-Based Microfluidics
por: Van Eyndhoven, Laura C., et al.
Publicado: (2021)

ICAM3-Fc Outperforms Receptor-Specific Antibodies Targeted Nanoparticles to Dendritic Cells for Cross-Presentation
por: Cruz, Luis J., et al.
Publicado: (2019)

Long-lasting multifunctional CD8(+) T cell responses in end-stage melanoma patients can be induced by dendritic cell vaccination
por: Wimmers, Florian, et al.
Publicado: (2015)

Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4(+) T cells after FcγRII-mediated uptake
por: Benitez-Ribas, Daniel, et al.
Publicado: (2006)

New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia
por: Jordaens, Stephanie, et al.
Publicado: (2020)

TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting
por: Peeters, Marlies J. W., et al.
Publicado: (2019)

Harnessing RNA sequencing for global, unbiased evaluation of two new adjuvants for dendritic-cell immunotherapy
por: Mathan, Till S.M., et al.
Publicado: (2017)

A novel category of antigens enabling CTL immunity to tumor escape variants: Cinderella antigens
por: Seidel, Ursula J. E., et al.
Publicado: (2011)

Thermal and mechanical high-intensity focused ultrasound: perspectives on tumor ablation, immune effects and combination strategies
por: van den Bijgaart, Renske J. E., et al.
Publicado: (2016)

Orchestrating an immune response against cancer with engineered immune cells expressing αβTCRs, CARs, and innate immune receptors: an immunological and regulatory challenge
por: de Witte, Moniek A., et al.
Publicado: (2015)

The specific targeting of immune regulation: T-cell responses against Indoleamine 2,3-dioxygenase
por: Andersen, Mads Hald
Publicado: (2012)

MHC-based detection of antigen-specific CD8(+) T cell responses
por: Hadrup, Sine Reker, et al.
Publicado: (2010)

Modeling flow cytometry data for cancer vaccine immune monitoring
por: Frelinger, Jacob, et al.
Publicado: (2010)

Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer
por: Sersa, Gregor, et al.
Publicado: (2015)

Immunotherapy of HPV-associated cancer: DNA/plant-derived vaccines and new orthotopic mouse models
por: Venuti, Aldo, et al.
Publicado: (2015)

How frequently are predicted peptides actually recognized by CD8 cells?
por: Moldovan, Ioana, et al.
Publicado: (2016)

4-1BB agonism: adding the accelerator to cancer immunotherapy
por: Chester, Cariad, et al.
Publicado: (2016)

Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer
por: Rojas-Sepúlveda, Daniel, et al.
Publicado: (2018)

Exercise and cancer: from “healthy” to “therapeutic”?
por: Idorn, Manja, et al.
Publicado: (2017)

Evolution of MHC-based technologies used for detection of antigen-responsive T cells
por: Bentzen, Amalie Kai, et al.
Publicado: (2017)

Unlocking the therapeutic potential of primary tumor-draining lymph nodes
por: Rotman, Jossie, et al.
Publicado: (2019)

Conventional CARs versus modular CARs
por: Feldmann, Anja, et al.
Publicado: (2019)

Monocytes reprogrammed with lentiviral vectors co-expressing GM-CSF, IFN-α2 and antigens for personalized immune therapy of acute leukemia pre- or post-stem cell transplantation
por: Bialek-Waldmann, Julia K., et al.
Publicado: (2019)

Lysyl oxidases: linking structures and immunity in the tumor microenvironment
por: Tenti, Paolo, et al.
Publicado: (2019)

Immune biological rationales for the design of combined radio- and immunotherapies
por: Hader, Michael, et al.
Publicado: (2020)

Long-term surviving cancer patients as a source of therapeutic TCR
por: Inderberg, Else Marit, et al.
Publicado: (2020)

Eradicating cancer cells: struggle with a chameleon
por: Di, Jiabo, et al.
Publicado: (2011)

Immunological responses to adjuvant vaccination with combined CD1c(+) myeloid and plasmacytoid dendritic cells in stage III melanoma patients
por: Bloemendal, Martine, et al.
Publicado: (2021)

The nature of activatory and tolerogenic dendritic cell-derived signal II
por: Bakdash, Ghaith, et al.
Publicado: (2013)

Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets
por: Sköld, Annette E., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f2a9bhodff2fvqhb8kn84c981g